← Evidence map

ArticleOncoTargets and therapy2017

Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.

Lingyi Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 28367059